tradingkey.logo
tradingkey.logo
Search

Calidi Biotherapeutics And City Of Hope Provide Update On A Phase 1 Clinical Trial With CLD-101 Virotherapy In Patients With Recurrent High-Grade Glioma

ReutersMar 26, 2025 12:06 PM
facebooktwitterlinkedin

- Calidi Biotherapeutics Inc CLDI.A:

  • CALIDI BIOTHERAPEUTICS AND CITY OF HOPE PROVIDE UPDATE ON A PHASE 1 CLINICAL TRIAL WITH CLD-101 VIROTHERAPY IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI